Advice Pool - Relationships

I've been around a while and always thought infatuation was the domain of the very young and somewhat silly. After all, didn't I have several infatuations when

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

I was 15 or 17? First, there was the girl in a mining company office where I had my first job. She was two years my senior, but sophisticated well above her yea

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

rs. Then there was my friend's mother, 26 years older. And over the ensuing year or two, a couple of others. Then of course, I grew up. Or so I thought.

Once I

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

began having real relationships the very idea of infatuation seemed like a childish pastime. That is until just recently when I fell victim to what I lat

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

er found is called "limerence", a much more mature form of involuntary infatuation.

You see, there is this woman at work to whom I was attracted not long after

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

we first met. She's very much younger that me and I realised that there was no real opportunity for a meaningful relationship, especially since I'm not only too

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

old for her, I'm also married.

I would have been happy with a platonic relationship if only I could have spent some time with her and been close friends. In f

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ct, my feelings for her were less physical and more about what I perceived as her youthful, exhuberent, lovely personality. And her intelligence. I thought she

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

was great to be around and she made me happy when we were together.

Then I began waking up early only to have her in my thoughts. I'd think of her on and off d

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ring every day and when I saw her it was like my dreams had come true ... at least when she talked to me. I couldn't believe that this young lady had taken cont

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

rol of my thoughts with absolutely no knowledge or intention on either her behalf or mine. That's part of what limerence is, what limerence does, even to much o

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

lder, mature people.

I had never heard the term limerence, but stumbled upon it during my research to find a solution. (See http://en.wikipedia.org/wiki/Limer

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

nce for full details).

My research told me that limerence cases often last for years. One way to dispense with it is to find another limerant object ... really

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

no solution at all. I told myself that I'm too smart, too experienced and simply too sensible for this to go on for years. After all, I was in charge of my des

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

iny. Right?

Apparently not. I've actively avoided contact with my "limerent object" at a number of social events and at work over the past few weeks with the h

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ope that my interest will simply fade away and take with it the emotional rollercoaster that is limerence. That's in fact made me unhappier because I feel that

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

am being unreasonable to her as an innocent party in all this.

Occasionally, when she passes in a hallway, she gives me a lovely smile and says, "Hi, Robin" a

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

nd it rocks me to the core. Just seeing her or hearing her voice sends my chemistry into chaos mode.

If only I could find in her some flaw, some bad thing perh

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ps, that would help change my mind. I can't. To me, she is perfect. It seems that there is simply no escape from limerence. It's a matter of hanging in there an

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

d toughing it out.

If you are ever unlucky enough to be caught in the limerence trap I'm afraid you'll just have to ride it out too.

Copyright 2006 Robin Henr

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/200352/advicepool-Can-We-Overcome-the-Power-of-Limerence.html">Can We Overcome the Power of Limerence?</a>

BB link (for phorums):
[url=http://www.advicepool.org.ua/article/200352/advicepool-Can-We-Overcome-the-Power-of-Limerence.html]Can We Overcome the Power of Limerence?[/url]

The sex appeal of great market research data often fades after it's presentation because companies don't know what to do with it.

These slow upward directional moves work well for covered call writers in two ways; capital appreciation and premium capturing.

This story outlines how I went to an Israeli folk dance, and how it reminds me of Krishna's Rasa dance. Dance is the eternal function of the soul in every culture throughout the entire planet since the beginning of time. But this type of dancing was material, temporary, perhaps an ancient memory of the REAL, eternal dance, transcendental in nature.

Tags

Links

Advice Pool - Can We Overcome the Power of Limerence?

Related Articles: